75 related articles for article (PubMed ID: 2009528)
21. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV
Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer.
Shibuta J; Eto T; Kataoka A; Inoue H; Ueo H; Suzuki T; Barnard GF; Mori M
Am J Gastroenterol; 2001 Dec; 96(12):3419-24. PubMed ID: 11774959
[TBL] [Abstract][Full Text] [Related]
23. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.
Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M
Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954
[TBL] [Abstract][Full Text] [Related]
24. Drug acetylator phenotypes in newborn infants.
Szórády I; Sánta A; Veress I
Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):23-5. PubMed ID: 3580445
[TBL] [Abstract][Full Text] [Related]
25. Acetylator polymorphism in rheumatoid arthritis.
Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
[TBL] [Abstract][Full Text] [Related]
26. Hepatic acetylator polymorphism in breast cancer patients.
Ladero JM; Fernández MJ; Palmeiro R; Muñoz JJ; Jara C; Lázaro C; Pérez-Manga G
Oncology; 1987; 44(6):341-4. PubMed ID: 3684174
[TBL] [Abstract][Full Text] [Related]
27. Acetylator phenotype in Iraqi patients with atopic dermatitis.
Najim RA; Al-Waiz MM; Al-Razzuqi RA
Dermatol Online J; 2006 Dec; 12(7):1. PubMed ID: 17459287
[TBL] [Abstract][Full Text] [Related]
28. CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancer.
Solerio E; Tappero G; Iannace L; Matullo G; Ayoubi M; Parziale A; Cicilano M; Sansoè G; Framarin L; Vineis P; Rosina F
Dig Liver Dis; 2005 Mar; 37(3):170-5. PubMed ID: 15888281
[TBL] [Abstract][Full Text] [Related]
29. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
30. Acetylation phenotypes in patients with bladder carcinoma.
Bicho MP; Breitenfeld L; Carvalho AA; Manso CF
Ann Genet; 1988; 31(3):167-71. PubMed ID: 3265609
[TBL] [Abstract][Full Text] [Related]
31. [Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].
Fengler JD; Baumgarten R; Eike E; Eike O; Siegmund W; Franke G; Zschiesche M
Z Gastroenterol; 1993 Feb; 31 Suppl 2():81-2. PubMed ID: 7483725
[TBL] [Abstract][Full Text] [Related]
32. Increased cancer risk in offspring of women with colorectal carcinoma: a Swedish register-based cohort study.
Planck M; Anderson H; Bladström A; Möller T; Wenngren E; Olsson H
Cancer; 2000 Aug; 89(4):741-9. PubMed ID: 10951335
[TBL] [Abstract][Full Text] [Related]
33. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus.
Kaufmann GR; Wenk M; Taeschner W; Peterli B; Gyr K; Meyer UA; Haefeli WE
Clin Pharmacol Ther; 1996 Jul; 60(1):62-7. PubMed ID: 8689813
[TBL] [Abstract][Full Text] [Related]
34. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
Grant DM; Mörike K; Eichelbaum M; Meyer UA
J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
[TBL] [Abstract][Full Text] [Related]
35. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats.
Purewal M; Velasco M; Fretland AJ; Hein DW; Wargovich MJ
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):529-32. PubMed ID: 10815700
[TBL] [Abstract][Full Text] [Related]
36. Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations.
Lewander A; Butchi AK; Gao J; He LJ; Lindblom A; Arbman G; Carstensen J; Zhang ZY; Sun XF;
Scand J Gastroenterol; 2007 Nov; 42(11):1332-8. PubMed ID: 17852842
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
38. Acetylator polymorphism in Parkinson's disease.
Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
[TBL] [Abstract][Full Text] [Related]
39. Diet, acetylator phenotype, and risk of colorectal neoplasia.
Roberts-Thomson IC; Ryan P; Khoo KK; Hart WJ; McMichael AJ; Butler RN
Lancet; 1996 May; 347(9012):1372-4. PubMed ID: 8637343
[TBL] [Abstract][Full Text] [Related]
40. Acetylator phenotype in psoriasis.
Jiménez-Nieto LC; Ladero JM; Fernández-Gundín MJ; Robledo A
Dermatologica; 1989; 178(3):136-7. PubMed ID: 2721804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
